Dan Miller is the Director of the Delaware Medicaid Fraud Control Unit, specializing in the civil and criminal prosecution of healthcare fraud cases. He has been a prosecutor for 15 years and has tried more than 125 jury trials. Mr. Miller served as the President of the National Association of Medicaid Fraud Control Units (NAMFCU), an organization whose members were responsible for securing more than 1,200 criminal convictions and returning more than $1.1 billion to the Medicaid Program last year. As a member of NAMFCU's Global Case Committee, Mr. Miller routinely works on healthcare fraud cases with national implications, such as the recent off-label marketing case against Eli Lilly, which was resolved for almost $1.5 million, and the nominal price case against Merck and Co., which settled in 2008 for $671 million. Previously, Mr. Miller served as co-chair of NAMFCU's Qui Tam Subcommittee where he coordinated communications and litigation positions for all states, which have enacted False Claims Acts. He is also an adjunct professor at Temple Law School teaching integrated trial advocacy. 

Laurence J. Freedman is a Partner at Patton Boggs, LLP where he defends clients against government investigations and litigation relating to allegations of fraud and abuse in the healthcare and life sciences industries. In addition to fraud enforcement matters, Mr. Freedman also counsels companies through internal investigations, corporate compliance, and investor due diligence reviews. He represents a broad range of healthcare clients, including pharmaceutical and device manufacturers, hospitals, durable medical equipment companies, clinical laboratories, and individual health care executives. Before joining Patton Boggs in 2005, Mr. Freedman served for seven years as an Assistant Director in the Department of Justice’s Civil Fraud Section. He devoted his efforts exclusively to healthcare fraud matters pursued under the False Claims Act and its qui tam (whistleblower) provisions, including cases premised on the Anti-Kickback Statute, the Stark laws (banning physician self-referral), and violations of the Food, Drug and Cosmetic Act. During this time, Mr. Freedman directly supervised hundreds of qui tam cases prosecuted by the section’s 70-plus attorneys in districts throughout the United States. He supervised multi-district, joint federal-state investigative efforts, and was part of the leadership team for DOJ’s Pharma Fraud Initiative. Mr. Miller graduated from Colgate University and the Yale Law School, and clerked for The Honorable Richard J. Cardamone of the United States Court of Appeals for the Second Circuit.

Arnold Friede is the Principal in Arnold I. Friede & Associates, which specializes in FDA-related legal and regulatory matters. Mr. Friede is a drug law counselor and advocate with significant advertising law, health care law, First Amendment, environmental, and commercial and transactional experience. He has a long history of representing clients in FDA-regulated matters beginning as an Associate Chief Counsel in the FDA Chief Counsel’s Office, and has a broad spectrum of senior in-house legal experience across multiple FDA-regulated industries. Mr. Friede served in government as a law clerk in Federal District Court in Los Angeles, then with the Federal Judicial Panel on Multidistrict Litigation in Washington, DC, and was an Associate Chief Counsel in the FDA Chief Counsel's Office in Rockville, Maryland. He also worked with Richardson-Vicks in Connecticut; with several divisions of Unilever United States, including as General Counsel of Unilever’s food business in New Jersey; as senior corporate counsel with Pfizer in New York; and as Counsel to the Washington, DC Office of McDermott Will & Emery. Mr. Friede has been involved for nearly 35 years in a broad range of FDA and other agency-regulated businesses, including the life sciences; such as pharmaceutical and biotech; medical device; medical information; disease management; over-the-counter drugs; and more. In addition to numerous other professional affiliations, he is a past Chairman of the Food, Drug, and Cosmetic Law Section of the New York State Bar Association. Mr. Friede is admitted to practice in California, Connecticut, the District of Columbia, and Maryland.

• Register online: Click here for the live webinar
• Register online: Click here for the live webinar PLUS recording
• Buy the recording: Click here for just the recorded webinar
• Register by email: custcare@elsevier.com
• Register by phone: 1 (800) 332-2181 (U.S.) / +1 (908) 547-2159 (non- U.S.)